| __timestamp | Teva Pharmaceutical Industries Limited | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 1244910 |
| Thursday, January 1, 2015 | 4717000000 | 5029636 |
| Friday, January 1, 2016 | 5096000000 | 4846776 |
| Sunday, January 1, 2017 | 4986000000 | 5329003 |
| Monday, January 1, 2018 | 4214000000 | 7121000 |
| Tuesday, January 1, 2019 | 3806000000 | 9128000 |
| Wednesday, January 1, 2020 | 3671000000 | 10731000 |
| Friday, January 1, 2021 | 3528000000 | 10701000 |
| Saturday, January 1, 2022 | 3445000000 | 16121000 |
| Sunday, January 1, 2023 | 3498000000 | 37021000 |
| Monday, January 1, 2024 | 3702000000 |
Cracking the code
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of key players is crucial. Over the past decade, Teva Pharmaceutical Industries Limited and Viking Therapeutics, Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses.
Teva, a giant in the pharmaceutical sector, has seen a significant reduction in its SG&A expenses, dropping by approximately 32% from 2014 to 2023. This decline reflects strategic cost-cutting measures and a focus on operational efficiency.
Conversely, Viking Therapeutics, a smaller yet dynamic player, has experienced a remarkable increase in SG&A expenses, growing nearly 29 times over the same period. This surge indicates aggressive expansion and investment in marketing and administrative capabilities.
These trends highlight the diverse strategies employed by pharmaceutical companies to navigate market challenges and opportunities.
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Intra-Cellular Therapies, Inc.
Operational Costs Compared: SG&A Analysis of Teva Pharmaceutical Industries Limited and Genmab A/S
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Dr. Reddy's Laboratories Limited
SG&A Efficiency Analysis: Comparing Teva Pharmaceutical Industries Limited and Ascendis Pharma A/S
Teva Pharmaceutical Industries Limited vs Corcept Therapeutics Incorporated: SG&A Expense Trends
Selling, General, and Administrative Costs: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Teva Pharmaceutical Industries Limited vs HUTCHMED (China) Limited
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Ascendis Pharma A/S and Viking Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Viking Therapeutics, Inc. or Xenon Pharmaceuticals Inc.
Viking Therapeutics, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Viking Therapeutics, Inc. and Wave Life Sciences Ltd.